Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 55.11

-2.6%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (13314)	10/5/2004 2:08:00 PM
From: Henry Niman	Read Replies (1) of 52153

CHIR has had its license suspeded, so I think the concern goes beyond the human flu vaccine, which was slated to be almost 50 million doses for the US this season. These things have a way of snowballing. First it was 1-2 million doses affected by contamination. Now it is all of this year's supply to the US. I don't think they get their license back aotomatically. They still have to prove that they can manufacture a safe product. Speaking of flu vaccine, CHIR is also working on an avian (H9N2) flu vaccine. The virus seems to be on the move and now is presenting like dengue fever recombinomics.com The virus seems to be several steps ahead of the vaccine manufacturers.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next